Assignee
ZHANG XITIAN
CN·2 granted patents·5 pending applications·0 citations·filing 2013–2018
Top patents by PatentIndex Score
7 records- 0141US2016129077A1Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanomaZHANG XITIAN·Filed 2014·Application pending·0 cites
- 0240US9789158B2Applications of recombined Ganoderma lucidum immunoregulation protein in preparing drugs for treating tissue fibrosisZHANG XITIAN·Filed 2014·Granted Oct 17, 2017·0 cites·2 claims
- 0338US12077566B2Mutants of recombinant immunoregulatory protein of Ganoderma lucidum and applications thereofZHANG XITIAN·Filed 2018·Granted Sep 3, 2024·0 cites·9 claims
- 0432US2016289280A1Fusion protein of recombinant ganoderma immunoregulatory protein and human serum albumin, preparation method thereof, and application thereofZHANG XITIAN·Filed 2014·Application pending·0 cites
- 0532US2016199439A1Application of recombinant immunoregulatory protein of ganoderma lucidum in preparation of drug for treating focal cerebral ischemiaZHANG XITIAN·Filed 2014·Application pending·0 cites
- 0630US2014221270A1Methoxypolyethyleneglycol succinimidyl propionate modified recombinant ganoderma immunoregulatory protein, preparing method and application thereofZHANG XITIAN·Filed 2013·Application pending·0 cites
- 0728US2015329601A1Methoxypolyethyleneglycol succinimidyl propionate modified recombinant Ganoderma Lucidum immunoregulatory protein, preparing method and application thereofZHANG XITIAN·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ZHANG XITIAN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →